Who are intranasal saline solution plus glycerol's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intranasal-saline-solution-plus-glycerol.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

intranasal saline solution plus glycerol — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

intranasal saline solution plus glycerol (intranasal saline solution plus glycerol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nasal decongestant/mucosal hydration agent. Area: Otolaryngology/Respiratory.

marketed Nasal decongestant/mucosal hydration agent Otolaryngology/Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

intranasal saline solution plus glycerol (intranasal saline solution plus glycerol) — Unidad de Investigacion en Enfermedades Cronico-Degenerativas. Intranasal saline solution with glycerol provides osmotic hydration and mucosal moisturization to the nasal passages.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
intranasal saline solution plus glycerol TARGET	intranasal saline solution plus glycerol	Unidad de Investigacion en Enfermedades Cronico-Degenerativas	marketed	Nasal decongestant/mucosal hydration agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nasal decongestant/mucosal hydration agent class)

Unidad de Investigacion en Enfermedades Cronico-Degenerativas · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). intranasal saline solution plus glycerol — Competitive Intelligence Brief. https://druglandscape.com/ci/intranasal-saline-solution-plus-glycerol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab